Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT set at €51.00 by JPMorgan Chase & Co.

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) was assigned a target price of €51.00 ($53.68) by financial analysts at JPMorgan Chase & Co. in a note released Tuesday to investors, Borsen Zeitung reports. JPMorgan Chase & Co.The stock’s price target would indicate a potential upside of 2.39% from the current stock price.

A number of other equity research analysts have also weighed in on FME recently. Jefferies Financial Group set a target price of €53.00 ($55.79) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, February 22 research report. Barclays set a target price of €68.00 ($71.58) on Fresenius Medical Care AG & Co. KGaA in a Tuesday May 31 research note. Berenberg Bank set a price target of €82.20 ($86.53) on Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday. Deutsche Bank Aktiengesellschaft set a price target of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, March 22. Finally, Deutsche Bank Rese… set a target price of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 report.

Shares of Share Fresenius Medical Care AG & Co. KGaA traded at €0.37 ($0.39) during midday trading on Tuesday, reaching €49.81 ($52.43). 488,692 shares of the company were traded, against an average volume of 704,197. The company has a 50-day simple moving average of €57.20 and a 200-day simple moving average of €57.66. The company has a debt ratio of 91.78, a current ratio of 1.26 and a quick ratio of 0.79. Fresenius Medical Care AG & Co. KGaA has a 52-week minimum of €50.10 ($52.74) and a 52-week maximum of €71.14 ($74.88). The company has a market capitalization of $14.60 billion and a P/E ratio of 16.63.

Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Further reading



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.